Tuesday, June 23, 2020 /08:51 PM / by WebTV/ Header Image Credit: Ecographics
WebTV's Market Review segment dedicated to #Coronanomics will be featuring a robust conversation on 'Focus On Neimeth Pharmaceutical: FY 2019 Performance & 2020 Market Outlook '.
Guest: Matthew Azoji
Date: Wednesday, June 24, 2020
Topic: Focus On Neimeth Pharmaceutical: FY 2019 Performance & 2020 Market Outlook
Highlights: Available later in the day with link to full video.
Host: Ottoabasi Abasiekong, Editor, WebTV
Co-Host: Boason Omofaye, Guest Analyst and CEO Frontier Africa Reports
Key Questions for Discussion
Mr Azoji graduated from the Obafemi Awolowo University, Ile-lfe, Osun State, where he obtained his B. Pharm (First Class Honours). He went on to obtain an MBA (Marketing) from the Enugu State University of Science and Technology, Enugu, and an Advanced Management Programme (AMP) from the Lagos Business School; Pan Atlantic University, Lagos.
He obtained certificates in Pharmaceutical Policy & Pharmacoeconomics from Utrecht University in the Netherlands (a WHO Collaborating centre), and went on to get his M.Sc. in Public health from the University of London, International Programmes. He obtained his M.Phil (Pharmacy Administration) from Obafemi Awolowo University, Ile-lfe. Presently, a PhD (Clinical Pharmacy & Pharmacy Practice) from the University of Jos, Jos Plateau State is in view.
Mr Azoji is Fellow, Pharmaceutical Society of Nigeria (FPSN) and Fellow, West African Postgraduate College of Pharmacists (FPCPHARM). He is a Member, International Pharmaceutical Federation (FIP), Founding Member, Health Systems Action Network (HSAN), Member, Nigerian Institute of Management (MNIM), Member, National Institute of Marketing of Nigeria and Member, Nigerian Association of Industrial Pharmacists.
He began his professional career as a Hospital Pharmacist at General Hospital Saminaka, Kaduna State in 1986 serving his National Youth Service Corps (NYSC) year. Prior to this, he had a one year internship programme at Obafemi Awolowo University, Ile-lfe as a Demonstrator/lnternee. He had a brief stint with Astra-Arewa Pharmaceuticals Ltd, Kaduna as a Medical Representative based in Kano. He joined May & Baker Nigeria Plc in 1988, and served there till 2004, during which time he rose from the position of Medical Representative to occupy the positions of Asst. Manager - Ethical Product Sales, Area Manager - North, Sales & Market Development Manager, Regional Sales Manager Lagos/South West, Business Manager - Healthcare, Business Manager - Consumer and Head, Corporate Planning & Development. He was the pioneer MD/CEO, CHAN Medi-Pharm Ltd/Gte, Jos, Plateau State from 2004 till September 2018.
Mr Azoji was briefly the Managing Director, leading the executive and management teams of Biovaccines Nigeria Ltd, a public-private partnership company between the Federal Government of Nigeria and May & Baker Nigeria Plc.
He served on the Boards of Ecumenical Pharmaceutical Network (EPN) and Africa Christian Health Associations Platform (ACHAP) both based in Nairobi, Kenya; contributing to enhance access to quality pharmaceutical and other health services to people in Africa and the rest of the world.
He is reputed to be a performance driven professional with over 20 years' experience at senior level as a leader in the pharmaceutical and public health sectors of Nigeria. With proven skills in managing Start-up businesses; Pharmaceutical Sales & Marketing, Public Health and Business Strategy, he is a strong business and product development professional with first class honours in Pharmacy, and three masters' degrees in Business Administration, Public Health and Pharmacy Administration. He is widely travelled, locally and internationally, and builds effective teams and partnership with diverse people.
DISCLOSURE: This content reflects the views of the author(s) drawing on prior research and experience in their areas of expertise. It is not a reflection of our institutional position; and is not a recommendation to buy or sell securities or the products mentioned therein. Proshare Content and their owners, managers, employees, and assigns (collectively the "Company") are bound to comply with in-house governance rules requiring this necessary disclosure to ensure that readers, subscribers and consumers understand what the content is. All T&C applies.